These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 18478316

  • 1. Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin.
    Lee JH, Lee MG.
    Pharm Res; 2008 Aug; 25(8):1915-24. PubMed ID: 18478316
    [Abstract] [Full Text] [Related]

  • 2. Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.
    Lee DY, Lee MG, Shin HS, Lee I.
    J Pharm Pharm Sci; 2007 Aug; 10(4):420-33. PubMed ID: 18261364
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
    Bae SK, Kim JY, Yang SH, Kim JW, Kim T, Lee MG.
    Life Sci; 2006 Apr 11; 78(20):2287-94. PubMed ID: 16288785
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin.
    Lee JH, Lee MG.
    Biopharm Drug Dispos; 2007 May 11; 28(4):157-66. PubMed ID: 17377958
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.
    Kim YC, Kang HE, Lee MG.
    Biopharm Drug Dispos; 2008 Jan 11; 29(1):51-61. PubMed ID: 18022993
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
    Kim YC, Lee AK, Lee JH, Lee I, Lee DC, Kim SH, Kim SG, Lee MG.
    Eur J Pharm Sci; 2005 Sep 11; 26(1):114-23. PubMed ID: 15985363
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
    Baek HW, Bae SK, Lee MG, Sohn YT.
    J Pharm Sci; 2006 Nov 11; 95(11):2452-62. PubMed ID: 16886191
    [Abstract] [Full Text] [Related]

  • 11. Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin.
    Choi YH, Lee DC, Lee I, Lee MG.
    J Pharm Sci; 2008 Dec 11; 97(12):5363-75. PubMed ID: 18393297
    [Abstract] [Full Text] [Related]

  • 12. Effects of diabetes mellitus induced by alloxan on the pharmacokinetics of metformin in rats: restoration of pharmacokinetic parameters to the control state by insulin treatment.
    Lee MG, Choi YH, Lee I.
    J Pharm Pharm Sci; 2008 Dec 11; 11(1):88-103. PubMed ID: 18445367
    [Abstract] [Full Text] [Related]

  • 13. Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.
    Kang HE, Sohn SI, Baek SR, Lee JW, Lee MG.
    Metabolism; 2010 Oct 11; 59(10):1472-80. PubMed ID: 20170928
    [Abstract] [Full Text] [Related]

  • 14. Time-dependent effects of Klebsiella pneumoniae endotoxin on the telithromycin pharmacokinetics in rats; restoration of the parameters in 96-hour KPLPS rats to the control levels.
    Lee JH, Cho YK, Jung YS, Kim YC, Lee MG.
    Pulm Pharmacol Ther; 2008 Dec 11; 21(6):860-5. PubMed ID: 18976719
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin.
    Kim YC, Oh EY, Kim SH, Lee MG.
    Biopharm Drug Dispos; 2005 Nov 11; 26(8):371-8. PubMed ID: 16094676
    [Abstract] [Full Text] [Related]

  • 16. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
    Lee JH, Lee MG.
    J Pharm Pharm Sci; 2007 Nov 11; 10(1):37-50. PubMed ID: 17498392
    [Abstract] [Full Text] [Related]

  • 17. Effects of Escherichia coli lipopolysaccharide on telithromycin pharmacokinetics in rats: inhibition of metabolism via CYP3A.
    Lee JH, Cho YK, Jung YS, Kim YC, Lee MG.
    Antimicrob Agents Chemother; 2008 Mar 11; 52(3):1046-51. PubMed ID: 18160519
    [Abstract] [Full Text] [Related]

  • 18. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
    Hu N, Xie S, Liu L, Wang X, Pan X, Chen G, Zhang L, Liu H, Liu X, Liu X, Xie L, Wang G.
    Drug Metab Dispos; 2011 Mar 11; 39(3):419-25. PubMed ID: 21135265
    [Abstract] [Full Text] [Related]

  • 19. Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.
    Srinivas NR.
    Eur J Drug Metab Pharmacokinet; 2015 Mar 11; 40(1):1-12. PubMed ID: 24596068
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin.
    Lee DY, Chung HJ, Choi YH, Lee U, Kim SH, Lee I, Lee MG.
    Eur J Pharm Sci; 2009 Dec 08; 38(5):465-71. PubMed ID: 19761842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.